Protagonist Therapeutics Financial Overview
Protagonist Therapeutics's market cap is currently $5.38B. The company's EPS TTM is $-0.62; its P/E ratio is 135.85; Protagonist Therapeutics is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.34. See an overview of income statement, balance sheet, and cash flow financials.
